Nano-Crystalline Megestrol Acetate Suspension
Colorectal Cancer
Changchun GeneScience Pharmaceutical Co., Ltd.Active
D
26/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 59/ 100
Competitive context
839 Active assets in the Colorectal Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Desflurane Peter MacCallum Cancer Centre, Australia | Phase 4 | BBB |
MARBLE DUST James Varani | Phase 2/3 | BB |
FLUOROURACILUM Washington University School of Medicine | Phase 4 | BB |
PANITUMUMAB M.D. Anderson Cancer Center | Phase 3 | BB |
Cetuximab Shanghai Henlius Biotech | Phase 4 | BB |
View all 50 →
Same molecule, other indications
Nano-Crystalline Megestrol Acetate Suspension is also rated in:
The Pre-cachexia or Cachexia Patients Who Have Not Received Systemic Treatment and Are Not Eligible for Curative TherapyDormant
B
Indicative ·
60 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →